FDA postpones some inspectional activities amid omicron surge

The FDA announced earlier this week that it made some temporary changes to its inspectional activities due to COVID-19.

With the omicron variant of the virus causing surges across the world, the FDA implemented the changes in the U.S. on Dec. 29, 2021, to ensure the safety of its employees and the firms it regulates, according to a news release.

Get the full story at our sister site, Medical Design & Outsourcing.